NEIDL in the News

Become A Donor

BU Gives $8,500 in Grants for Summer Programs and Local Non-Profit

For Immediate Release: August 7, 2013 Contact: Ellen Berlin (617) 520-7115, eberlin@webershandwick.com Valeda Britton, (617) 638-1911, vjbritto@bu.edu BU GIVES $8,500 IN GRANTS FOR SUMMER PROGRAMS AND LOCAL NON-PROFIT (Boston) — Boston University recently gave $8,500 to help aid programs that support Roxbury's arts and cultural environment as well as a summer biotech program for local... More

Lessons from a Hot Zone

Original article from: Bostonia, By Nancy Brady “NANCY, WE HAVE A PROBLEM.” I looked squarely into the eyes of Bruno, our data manager, trying to gauge his concern. It was a phrase I was accustomed to hearing. I was spending the summer of 2012 working in public health centers in Kibaale, a rural... More

Fighting H1N1 with Tobacco Plants

Original article from: Bostonia, By Amy Laskowski After decades of demonization as a health menace, the tobacco plant is about to become a source of potentially lifesaving medicines, thanks in part to the work of Andre Sharon. Sharon leads a team that built a fully automated factory that uses synthetically altered tobacco plants... More

Boston University Study Identifies Molecular Circuitry That Helps Tuberculosis Survive for Decades

Original press release from: Boston Medical Center, posted on July 3, 2013. By Gina DiGravio Contact: Gina DiGravio gina.digravio@bmc.org 617-638-8480 Boston University Medical Center (Boston) – In a study from Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), researchers have generated a map of the cellular circuitry ofMycobacterium tuberculosis, the causative agent of human tuberculosis... More

Emergency Drill to be Conducted at National Emerging Infectious Diseases Laboratories

For Immediate Release: June 3, 2013 Contact: Ellen Berlin (617) 520-7115, eberlin@webershandwick.com EMERGENCY DRILL TO BE CONDUCTED AT NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (Boston) – On Wednesday, June 12th at approximately, 9:00 a.m., Boston University (BU) will conduct a full-scale emergency response drill at the National Emerging Infectious Diseases Laboratories (NEIDL)... More

Emergency Response Exercise Planned for NEIDL

For Immediate Release, March 19, 2013 Contact:  Ellen Berlin, 617 520 7115, eberlin@webershandwick.com Emergency Response Exercise Planned for NEIDL March 19, 2013--On Wednesday, March 27, 2013, a discussion-based emergency response exercise will be taking place at Hiebert Lounge, located in the School of Medicine, as part of its ongoing safety and training program. In... More

Boston University Biolab wins State Approval of its Environmental Review

Original article from: Boston Globe, posted on March 1, 2013. By Chelsea Conaboy Boston University’s bid to study some of the world’s deadliest infectious diseases in a South End laboratory has cleared another regulatory hurdle. The state secretary for environmental affairs issued a certificate Friday indicating that an environmental impact report submitted... More

State Approves NEIDL Biosafety Level 3, 4 Research

BU Today March 4, 2013 by Art Jahnke In an action that moves BU’s National Emerging Infectious Diseases Laboratories(NEIDL) closer to full operation, the Massachusetts Secretary of Energy and Environmental Affairs has given approval for the lab to conduct research at Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4). The state agency issued... More

State Issues MEPA Certificate Approving Research at Boston University’s National Emerging Infectious Diseases Laboratories

For Immediate Release: March 1, 2013 Contact:  Steve Burgay, 617-353-1168, burgay@bu.edu State Issues MEPA Certificate Approving Research at Boston University’s National Emerging Infectious Diseases Laboratories (Boston) — The Massachusetts Secretary of Energy & Environmental Affairs announced that he has issued a Massachusetts Environmental Policy Act (MEPA) certificate for Boston University’s National Emerging... More

Opposition still wary of Biolab despite NIH Risk Assessment

The Daily Free Press January 15, 2013 by Margaret Waterman Although the National Institutes of Health handed down a decision affirming Boston University’s National Emerging Infectious Diseases Laboratories poses minimal risk to the surrounding community, the opposition remains skeptical of its safety. Councilor Tito Jackson, of Roxbury, said he is disappointed by the assessment... More

Biolab Gets Fed OK But Hurdles Remain

The Boston Courant January 11, 2013 by Zach Huffman State approval and the resolution of state and federal lawsuits are the next hurdles that the BU biolab has to contend with before it can begin working with lethal biosafety level 4 pathogens. The National Institutes of Health (NIH) issued their approval for the... More

NIH concludes that BU biolab Poses Minimal Risk to Community; Decision comes after thorough and Comprehensive Analysis

The Bay State Banner January 10, 2013 The National Institutes of Health (NIH) recently concluded that Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) poses minimal risk to the surrounding community. The issuance of the Supplemental Record of Decision follows a thorough and comprehensive analysis by distinguished scientists and researchers... More

BU Awards Community Grants Supporting Youth Organizations in South End and Roxbury

FOR IMMEDIATE RELEASE, January 10, 2013 Contact: Ellen Berlin    eberlin@webershandwick.com 617-520-7115 (Boston) - Boston University today announced two grants of $2,500 to local community organizations offering programs and services that benefit youth in the South End and Roxbury. The two recipients are Boston City Lights and Mandela Resident Cooperative Association, Inc. (MRCA). More

Feds clear BU Biolab to study Ebola Virus, Yellow Fever

Boston Business Journal January 3, 2013 by Julie M. Donnelly The long held-up National Emerging Infectious Disease Laboratory (NEIDL), commonly referred to as the BU Biolab, has been cleared by federal health officials to study dangerous agents such as West Nile virus, Yellow Fever, SARS, small pox and ebola virus. The National Institutes of... More